$HCAT News

Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026

Data Analytics Stocks Q2 Results: Benchmarking Health Catalyst (NASDAQ:HCAT)

Health Catalyst (HCAT): Buy, Sell, or Hold Post Q2 Earnings?

Health Catalyst Reports Q2 2026 Results: Full Earnings Call Transcript

Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Health Catalyst Strengthens Its Board with the Appointment of Tami Reller

Health Catalyst appoints new CEO

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

Health Catalyst to Participate in Upcoming Investor Conference

Canaccord Genuity Downgrades Health Catalyst to Hold, Lowers Price Target to $1.8

5 Must-Read Analyst Questions From Health Catalyst’s Q2 Earnings Call

Health Catalyst (HCAT) Q2 2026 Earnings Call Transcript

Wells Fargo Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $1.5

Citigroup Maintains Neutral on Health Catalyst, Lowers Price Target to $2

HCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline

Why Health Catalyst (HCAT) Shares Are Trading Lower Today

Health Catalyst, Inc. Q2 2026 Earnings Call Summary

Health Catalyst Q2 Earnings Call Highlights

Health Catalyst Shares Tumble Overnight: What Investors Need to Know

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics